Cyclopharm Ltd
ASX:CYC
Intrinsic Value
The intrinsic value of one CYC stock under the Base Case scenario is 3.27 AUD. Compared to the current market price of 1.07 AUD, Cyclopharm Ltd is Undervalued by 67%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Cyclopharm Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Cyclopharm Ltd
Balance Sheet Decomposition
Cyclopharm Ltd
Current Assets | 42.4m |
Cash & Short-Term Investments | 20.6m |
Receivables | 7.7m |
Other Current Assets | 14.2m |
Non-Current Assets | 19.7m |
PP&E | 13.1m |
Intangibles | 5.9m |
Other Non-Current Assets | 745.6k |
Free Cash Flow Analysis
Cyclopharm Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
Cyclopharm Ltd
Revenue
|
27.6m
AUD
|
Cost of Revenue
|
-9.6m
AUD
|
Gross Profit
|
17.9m
AUD
|
Operating Expenses
|
-32.4m
AUD
|
Operating Income
|
-14.5m
AUD
|
Other Expenses
|
1.3m
AUD
|
Net Income
|
-13.2m
AUD
|
CYC Profitability Score
Profitability Due Diligence
Cyclopharm Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
Cyclopharm Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
CYC Solvency Score
Solvency Due Diligence
Cyclopharm Ltd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Score
Cyclopharm Ltd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CYC Price Targets Summary
Cyclopharm Ltd
According to Wall Street analysts, the average 1-year price target for CYC is 2.75 AUD with a low forecast of 2.73 AUD and a high forecast of 2.84 AUD.
Dividends
Current shareholder yield for CYC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one CYC stock under the Base Case scenario is 3.27 AUD.
Compared to the current market price of 1.07 AUD, Cyclopharm Ltd is Undervalued by 67%.